<h4>Background</h4>The glucagon-like peptide-1 receptor (GLP-1R) agonist liraglutide is an effective therapeutic agent for obesity, primarily through its ability to suppress appetite and delay gastric emptying. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.